Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 4:19 PM
Ignite Modification Date:
2025-12-25 @ 2:16 PM
NCT ID:
NCT04075266
Pre Assignment Details:
A total of 23 participants with relapsing-remitting multiple sclerosis (RRMS) received ocrelizumab per a weight-based dosing regimen.
Recruitment Details:
Participants took part in the study across 12 investigative sites in 3 countries (the United States, Poland, and Italy). This study is still ongoing.
Study:
NCT04075266
Study Brief:
Results Section:
NCT04075266